Syed A. Haq

MD, Green Life Center For Rheumatic Care And Research
Dhaka, C, Bangladesh

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 63 publications

Prevalence of Comorbidities and Poor Prognostic Factors Among Patients With Rheumatoid Arthritis in Bangladesh.

Prevalence of Comorbidities and Poor Prognostic Factors Among Patients With Rheumatoid Arthritis in Bangladesh.

Journal: The Journal of rheumatology

Published: April 01, 2026

Interventions aimed at advancing gender equity in rheumatology: Insights from the Coalition for Health and Gender Equity (CHANGE) survey.

Interventions aimed at advancing gender equity in rheumatology: Insights from the Coalition for Health and Gender Equity (CHANGE) survey.

Journal: Autoimmunity reviews

Published: March 20, 2026

Efficacy and Safety of Tofacitinib Compared to Cyclophosphamide in Early Diffuse Cutaneous Systemic Sclerosis: A Randomized Controlled Trial.

Efficacy and Safety of Tofacitinib Compared to Cyclophosphamide in Early Diffuse Cutaneous Systemic Sclerosis: A Randomized Controlled Trial.

Journal: Cureus

Published: February 05, 2026

Baricitinib in moderate to severe rheumatoid arthritis: dose-dependent efficacy and safety in a randomized clinical trial in a developing country.

Baricitinib in moderate to severe rheumatoid arthritis: dose-dependent efficacy and safety in a randomized clinical trial in a developing country.

Journal: BMC rheumatology

Published: December 15, 2025

Pilot Retrospective Evaluation of a Balancing and Optimizing Injection Pattern for the Frontalis Muscle Using LetibotulinumtoxinA.

Pilot Retrospective Evaluation of a Balancing and Optimizing Injection Pattern for the Frontalis Muscle Using LetibotulinumtoxinA.

Journal: Toxins

Published: October 12, 2025

Experience with Use of Rituximab in Different Connective Tissue Diseases in Bangladesh.

Experience with Use of Rituximab in Different Connective Tissue Diseases in Bangladesh.

Journal: Mymensingh medical journal : MMJ

Published: September 30, 2025

Comparative Efficacy and Safety of Thalidomide and Sulfasalazine in Moderate to Severe Ankylosing Spondylitis: A Real-World Study From Bangladesh.

Comparative Efficacy and Safety of Thalidomide and Sulfasalazine in Moderate to Severe Ankylosing Spondylitis: A Real-World Study From Bangladesh.

Journal: Cureus

Published: June 17, 2025

Efficacy, Safety, and Immunogenicity of Biosimilar Adalimumab Advixa® Compared With Reference Product Humira® in Patients With Rheumatoid Arthritis in Bangladesh.

Efficacy, Safety, and Immunogenicity of Biosimilar Adalimumab Advixa® Compared With Reference Product Humira® in Patients With Rheumatoid Arthritis in Bangladesh.

Journal: Cureus

Published: January 18, 2025

Urinary Tract Infection in Systemic Lupus Erythematosus: Report from A Developing Country.

Urinary Tract Infection in Systemic Lupus Erythematosus: Report from A Developing Country.

Journal: Mymensingh medical journal : MMJ

Published: December 31, 2024

2023 Management Recommendations of Bangladesh Rheumatology Society on Pharmacological Treatment of Rheumatoid Arthritis With Synthetic and Biologic Disease-Modifying Drugs.

2023 Management Recommendations of Bangladesh Rheumatology Society on Pharmacological Treatment of Rheumatoid Arthritis With Synthetic and Biologic Disease-Modifying Drugs.

Journal: Cureus

Published: April 30, 2024

How Low Back Pain is Managed-A Mixed-Methods Study in 32 Countries. Part 2 of Low Back Pain in Low- and Middle-Income Countries Series.

How Low Back Pain is Managed-A Mixed-Methods Study in 32 Countries. Part 2 of Low Back Pain in Low- and Middle-Income Countries Series.

Journal: The Journal of orthopaedic and sports physical therapy

Published: April 11, 2024

Ready-to-use abobotulinumtoxinA solution versus powder botulinumtoxinA for treatment of glabellar lines: Investigators' and subjects' experience in a Phase IV study.

Ready-to-use abobotulinumtoxinA solution versus powder botulinumtoxinA for treatment of glabellar lines: Investigators' and subjects' experience in a Phase IV study.

Journal: Journal of cosmetic dermatology

Published: February 15, 2024

Showing 1-12 of 63

Last Updated: 09/26/2026